Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Reshma Ramracheya

Reshma Ramracheya

Oxford Centre for Diabetes, Endocrinology & Metabolism University of Oxford UK

Amy Articolo

Amy Articolo

Vice President of Obesity Treatment Foundation USA

Edita Stokić

Edita Stokić

Edita Stokić Clinical Center of Vojvodina Serbia

Mathias A. Fobi

Mathias A. Fobi

International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) USA

Hidekatsu Yanai

Hidekatsu Yanai

National Center for Global Health and Medicine Kohnodai Hospital Japan

Cliodhna Foley Nolan

Cliodhna Foley Nolan

Director of Human Health & Nutrition, Safefood Ireland

Hiro Yoshida

Hiro Yoshida

Harvard Medical School USA

Dr. Kaiser Raja

Dr. Kaiser Raja

Aster Liver Care UAE

Metabolic Diseases Meet 2019

About Conference


About Conference                                                      

               ME Conference has the enormous pleasure in organising “INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ during 27-28 of May in Istanbul, Turkey. This conference is an exposed platform for Researchers, Aspiring students, Directors, Professors, Scientists, Academicians and Young researchers of life science department to present their diligent work in front of prominent personalities of the same field. The thoughts and work of the scholastic individuals can be presented in the shape of verbal presentations, poster presentations and video presentations who are interested to gain global appreciation and to add progression to human lives from their work. This conference offers wider knowledge in liver cancer and metabolic diseases thereby providing futuristic approaches to treat them in the near future.

Why to attend?

                                        “THE ONLY SOURCE OF KNOWLEDGE IS EXPERIENCE”

“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it gives exposure in an international way for people who attend and experience for people who present their work in front of people expertized in the area of Hepatology and Human metabolism.

Target Audience

                Anaesthesiologist

                Clinical Research Associates

                Diabetes Educators

                Dieticians

                Genetic Counsellor

                Healthcare Professionals

                Industrialists

                Medical Oncologists

                Metabolic Professionals

                Medicinal Professionals

                Nutritionists

                Pharmacologists

                Professors

                Radiation Oncologists

                Research, Healthcare Scientists

                Surgical Oncologists

 

Scientific Sessions

Track1. Types of Metabolic Diseases

Metabolic disease broadly occurs in human body due to the alteration in the biochemical pathways and this is normally because of an autosomal recessive gene. This interruption in the normal metabolism leads to weight loss, jaundice, injury and dullness which finally indicates the presence of diseases like Diabetes MellitusObesity, Gaucher’ s disease in the individual. In some cases abnormal metabolic mechanism leads to liver cancer with cirrhosis being its backbone causative factor. Liver cancer is the sixth leading cancer worldwide with advancing mortality rate year by year.

Track2. Metabolic Reactions and Nutrition

Nutrition is the measure of Carbohydrates, Proteins, Vitamins, Minerals and fat components that we intake regularly. There is an incongruity in the mechanism when there is lack or change in the composition of the nutrients. Hence Nutrition and Human Metabolism are proportional and when there is an alarming signal in the proportionality level it leads to nutritional deficiencies, abnormal chemical reactions and disease in organs involving the metabolism.

Track3 Pediatric Metabolic Disorders

Metabolic disorders in children are more due to genetic inheritance. There are constant sorts of metabolic clutters more up to date that keep popping all over the globe with deadly complications. General symptoms among all metabolic disorders are lethargy, abdominal pain, delay in development and weight loss. DNA testing and Genetic Counselling are prepared to identify and diagnose metabolic disorders.

Track4. Metabolic Syndrome

Metabolic syndrome is a combination of risk factors which includes high blood pressure, hypo and hyperglycemia, abnormal cholesterol levels and excess body fat around the waist that occur together, doubling your risk of heart disease, stroke, and diabetes.  This condition is also known by other names including Syndrome X, insulin resistance syndrome, and dysmetabolic syndrome. Insulin resistancemetabolic syndrome and prediabetes have overlapping aspects and are closely linked to one another. Most of the disorders associated with metabolic syndrome have no symptoms, although it is closely linked to insulin resistance, overweight or obesity and inactivity. Metabolic syndrome can be prevented or reversed by adopting few number of lifestyle changes, including losing weight, regular exercise, healthy diet, stopping smoking, and cutting down on alcohol.

Track5. Diabetes-A Common Entity

Diabetes is all affront levels and sugar levels and what we put in our body. Type 2 Diabetes is the most general among the rest of the two types (Type 1 Diabetes, gestational Diabetes). The mechanism is all about the functioning of insulin in our body. Depositing insulin generated in our body will lead to health problems like Diabetes mellitus. A1C test, Fasting plasma glucose (FPG) test, Random plasma glucose (RPG) test,  are the clinical diagnosis prepared to analyse the presence of Glucose levels in human body. Regular testing and proper diet will automatically transform the maintenance of blood sugar level.

Track6. Obesity and Bariatric Surgery

Obesity impairs the prosperity and individual fulfilment of a growing number of People. Hence national governments and the National Commission have dispersed liberal advantages for find how to switch this example. Disregarding the way that we know as extraordinary course of action about body weight control structures and that these are affected by genetic traits, the present rate in corpulence in every country is hugely influenced by way of life, diet patterns and physical exercise.

Track7. Emerging therapies for Metabolic Disorders

Bioinformatics tool contribute the basic capabilities to approach Metabolic Disorders in various dimensions. Bioinformatics Algorithms and devices are basic to investigate and translate information from microarrays. Thus, microarray investigation gives a phenomenal possibility to encourage the understanding of the etiology and movement of liver cancer. Bariatric surgery which is an approaching remedy will also decrease the risk of Type 2 Diabetes which thereby prevents a person from any metabolic disorders and Liver Cancer.

Track8. Hepatocellular Carcinoma

The molecular targets of stake have expanded from angiogenesis to cancer cell-directed oncogenic signalling pathways for advanced HCC treatment .The feasibility of combining locoregional therapeutic agents and targeted agents, and the use of novel agents after restorative treatments are currently under active investigation. Finally, the therapeutic response has shifted from monotherapy to blend targeted therapy.

Track9. Liver Diseases

Liver is responsible for several vital functions within the body. It assists your body digest food, store energy, and remove poisons. There are over 100 various forms of liver disease that affect men, women and children. These diseases involve liver cirrhosisalcohol abuse; hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The primary symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Track10. Hepatitis B

Hepatitis B is a liver contagion caused by the Hepatitis B virus (HBV). HBV is transferred through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can outlive outside the body at least 7 days and still be capable of causing infection. The best way to inhibit hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the synergy of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma.

Track11. Hepatitis C

Hepatitis C is a deadly viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often exorbitant complications emerge as a result of damage to the liver. It is evaluates that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on growing improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be conceivably cured.

Track12. Gastroenterology

Gastroenterology is the study of comprehensive understanding of the physiology of the gastrointestinal organs including the movement of material through the stomach and intestine the digestion and absorption of nutrients into the body, elimination of waste from the system, and the function of the liver as a digestive organ.

Track13. Next Generation Ideology towards Metabolic Disorders

Next Generation Techniques advances with genomic, epigenomic and translational molecular layers for analysis. Next Generation Sequencing(NGS) approaches guarantee a worldwide see on oncogenomics by encouraging integrator and proficient discovery of hereditary and epigenetic changes in cancer at a single-base determination. Ultrasonography, Chorionic Villus Sampling (CVS), maternal blood sampling for fetal DNA, Pediatric Surgeries, Kovatchev's artificial pancreas are the most essential ideas that are being and soon will be an reasonable option in treating Metabolic diseases.  

Track14. Healthcare Management -An Alternative Remedy

As correctly the Proverb says “Health is Wealth’’, taking care of one’s is very important to live a disease free life which spontaneously gives us a wealthy life. But to consider only 10 countries in the world are calculated to be healthiest countries. Even the resources are accessible at most places still only 10 countries have the healthiest people among 195 countries rest.  Healthcare includes prevention, diagnosis, cure of disease, illness, injury, and other physical and mental impairments. For a healthy and wealthy life one can concentrate more on his/her health by feeding it with good thoughts, good food and exercises which relaxes one from stress and mental illness. Proper Diet and appropriate exercise paves way for a disease free life.


Market Analysis

         Cancer is considered to be the foremost cause death globally by statistical reports and the report also obviously gives information that the low- and middle-income countries around the world are been mostly affected. Tobacco use, alcohol use, unhealthy diet, and chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Human Papilloma Virus (HPV) are leading risk causes for cancer in low- and middle-income countries. With emerging advanced technics and researches in treating cancer there is a hope for many cancer survivors for a long time survival. There are later improvements in the cancer medications & cancer care is quickening. A batch of inventive solutions, regularly common with other modern or existing arrangements, and routinely related with biomarkers, is rising from the imaginative work pipeline. In the course of recent years, 70 modern oncology drugs have been instigated and are being utilized to treat more than 20 assorted tumor types. Yearly around the world advancement in the oncology medicate display is required to be 7.5 – 10.5 % through 2020, accomplishing $150 billion. More broad application of modern items—particularly immunotherapies will drive awesome portion of the improvement, counteracted by reduced utilization of a few current medications with average clinical results. The perception that cancer rate is distinct around the world, that it changes over time, and that transients from low-risk nations accomplish the hazard of counting physical, chemical, and natural elements in the living and occupational environment as well as behavioural and sociocultural variables such as slim down, smoking, liquor consumption, and fertility. The frequency of Metabolic Disease found is similar to that in developed countries, being influenced by age, body mass index, educational levels, physical activity, and leading to a higher frequency of cardiovascular complications after the 4th decade of life.

 

STATISTICAL REPORT ON WORLDWIDE CANCER

It is estimated that almost 1.7 million new cases of cancer are been diagnosed every year and it’s been increasing year by year.. Prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers. Among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common.

WORLWIDE REPORT ON CAUSES OF METABOLIC DISORDERS

The study presented that 22.7% of the population has metabolic disorder, which increments with age, higher BMI and inactive way of life. There was no critical difference between genders until age ≥70 a long time and social classes. Injury to genes may be due to internal factors, such as hormones or the metabolism of nutrients within cells, or external factors, such as tobacco, chemicals, and sunlight. It is considered that 5%-10% of all metabolic diseases are strongly hereditary, meaning that individuals who inherit a specific genetic alteration have a very high risk of developing a particular disorder. It is conception that many metabolic disorders result from a combination of hereditary and environmental factors.

TOP MOST AFFECTED COUNTRIES

Why Istanbul, Turkey?

Istanbul is one of the world’s prime places for any international events or conferences & a growing knowledge hub. Istanbul is furthermore very positioned on the International Congress and Convention Centre’s city rankings for gatherings in every on-going year. Istanbul developed as a global city and business hub of the Middle East. With all its treasure and pleasure Istanbul concentrates more on the research work. As per the statistics the people in Istanbul suffer from cancer and it is one of accounts for the increase in death rate. There are also associations which act on managing the healthcare of the children and adults from any metabolic disorders and liver cancer. Istanbul will be a incredible destination to conduct Metabolic Diseases Meet and to bring out the rays of hope in treating Liver Cancer and Metabolic Disorders globally.

Societies related with Cancer and Metabolic Diseases:

Saudi Cancer Society, Dubai, UAE.

Saudi oncology society and Saudi urology association, Dubai, UAE.

Saudi Arabia Cancer Organizations and Resources, Dubai, UAE.

Malaysian Oncology Society, Malaysia.

Malaysian Society of Paediatric Haematology and Oncology, Malaysia.

American Association for Cancer Research, USA.

American Brain Tumor Association, USA.

American Cancer Society, USA.

American Society for Radiation Oncology, USA.

American Society of Clinical Oncology, USA.

European Association for Cancer Research, Europe.

Association for International Cancer Research AICR, UK.

Association of European Cancer Leagues, Europe.

European Oncology Nursing Society, Europe.

European Society for Medical Oncology, Europe.

European Society of Surgical Oncology, Europe.

German Society for Digestive and Metabolic Diseases,Germany.

Acoustic Neuroma Association of Australia, Australia.

Clinical Oncological Society of Australia, Australia.

Asian Society for Neuro-Oncology, Asian.

Society For Inherited Metabolic Disorders, California.

Worldwide

University of Chicago, Chicago

University of Toronto, Canada

Washington University in St. Louis

Thomas Jefferson University

National University of Singapore (NUS), Singapore

Indianapolis University “La Sapienza” of Rome, Rome, Italy

University of Wisconsin, Madison-

University of Tokyo, Japan

Guangxi Medical University, Nanning, China

University of Lyon, France

University Of Leeds

University Of Queensland, Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

University of Southampton

University of Pittsburgh

McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

MAJOR COMPANIES FOCUSSING ON LIVER CANCER AND RESEARCH

Amadix

Alimta

Assembly Biosciences

Sirtex

Bayer

Conatus Pharmaceuticals

Dicerna Pharmaceuticals

Enanta Pharmaceuticals

FibroGen

Oncovision

Glaxosmithkline

Madrigal Pharmaceuticals

Novartis

Pfizer

Intercept Pharmaceuticals

Roche

Genomica

NorayBio

Major Hospitals Worldwide

Abbott Northwestern Hospital, Minneapolis, MN  

Advocate Lutheran General Hospital, Park Ridge, IL  

Allegheny General Hospital, Pittsburgh, PA  

Baptist Hospital of Miami, Miami, FL  

Barnes-Jewish Hospital/Washington University, St. Louis, MO  

Boston Medical Center, Boston, MA  

Brigham and Women's Hospital, Boston, MA  

California Pacific Medical Center CA Campus, San Francisco, CA  

Case Western Reserve University  

Cedars-Sinai Medical Center, Los Angeles, CA  

Christiana Care, Newark, DE  

Cleveland Clinic, Cleveland, OH  

Columbia University Medical Center 

Cornell University, Weill Medical College  

Dartmouth Medical School

Related Conferences:  Cancer Treatment and Drug therapy  | Genetics and Epigenetics of Cancer  | Metabolic disorders  | Metabolic Syndrome Conferences  | Oncologists Meetings

MAJOR ASSOCIATIONS AND SOCIETIES:

EUROPE: Blue Faery - The Adrienne Wilson Liver Cancer AssociationEuropean Association for the Study of the LiverAssociation of Community Cancer Center, Childhood Cancer Research GroupWorld Hepatitis AllianceThe International Liver Cancer AssociationThe International Diabetes FederationBelgian Association for Metabolic DiseasesBritish Inherited Metabolic Disease GroupThe European Association for the Study of ObesityBritish Association for Community Child HealthGerman Society of Radiation OncologyNational Cancer CouncilRadiation Therapy Oncology Group,Canadian Cancer Society

USA: American Association for the Study of Liver DiseasesAmerican Society of Clinical OncologyCanLiv -The Hepatobiliary Cancers FoundationAmerican Association for Cancer ResearchAssociation for the Study of Lung CancerCanadian Association of Radiation OncologySociety For Inherited Metabolic DisordersAmerican Diabetes AssociationThe Obesity SocietyChild Health Association Of SewickleyAmerican Society for Blood & Marrow Transplantation

MIDDLE EAST AND ASIA PACIFIC: The Asian Pacific Association for the Study of the Liver,The Asia-Pacific Primary Liver Cancer Expert AssociationThe Japan Society of Hepatology, Indian Cancer SocietyAssociation of Radiation Oncologists of IndiaAustralian Association of Smoking Cessation ProfessionalsAustralasian Hepatology AssociationSouth Asian Association for the Study of the LiverObesity Surgery Society of IndiaSaudi Oncology SocietyNew Zealand Bone Marrow Donor RegistrySaudi Arabia Cancer Organizations and ResourcesMalaysian Oncology Society

Past Conference Report

Metabolic Diseases 2018

Thanks to all our momentous speakers, delegates, and all the conference attendees contributed for the success of International Conference on Diabetes and Cholesterol Metabolism (Metabolic Diseases 2018) convoked by ME Conferences during October 15-17, 2018 was successfully held at Radisson Blu Hotel, Dubai Deira Creek, Dubai, UAE with a theme “Be stronger than Diabetes” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Metabolic Diseases 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Endocrinology, Diabetes, Pediatrics, and Surgery.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Diabetes Mellitus
  • Diabetes Chronic Complication
  • Biomarkers for Diabetes
  • Diabetes Research
  • Treatment Of Diabetes
  • Endocrinology
  • Insulin Medication
  • Cholesterol Metabolism and Diabetes
  • Metabolic Syndrome
  • Biology of Diabetes
  • Transplantation/ Immunology
  • Genetics of Diabetes
  • Diabetes Medication & Therapy

Metabolic Diseases 2018 Organizing Committee would like to thank the Moderators of the conference, Najamunissa Basha, Newcastle Medical Centre, UAE who has contributed a lot for the smooth functioning of this event.

Metabolic Diseases 2018 extends its warm gratitude to all the Honourable Guest and Keynote Speakers of the event:

  • Gerald C Hsu, EclaireMD Foundation, USA
  • Keshena Patterson, Siemens Healthineers, USA
  • Nabil Al-Kayssi, University of Alberta, Canada
  • Apurva Vyas, Radiance Hospital, India
  • Rama Adnan Mnla, Imperial college Diabetes Centers, UAE
  • Mohamad Miqdady, Sheikh Khalifa Medical City, UAE
  • Mayssa Adnan Traboulsi, Lebanese University, Lebanon
  • Najamunissa Basha, Newcastle Medical Centre, UAE
  • Samra Abouchacra, University of Toronto Medical School, Canada
  • Oudi Abouchacra, Parker University, Texas

ME conferences is privileged to felicitate Metabolic Diseases 2018 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. ME conferences would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.

With the valuable feedback received from the participants of Metabolic Diseases 2018, Conference Series LLC is glad to announce the commencement of “International Conference on Diabetes and Cholesterol Metabolism” during November 25-26, 2019 at Helsinki, Finland. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing diabetes and its concomitant risk factors.

 

 

To Collaborate Scientific Professionals around the World

Conference Date May 27-28, 2019

Speaker Opportunity

Supported By

Journal of Liver Journal of Endocrinology & Metabolic Syndrome Journal of Metabolic Syndrome Journal of Diabetes & MetabolismJournal of Diabetes & Metabolism

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

mediapartner

Media Partner

Collaboration

Collaboration

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Ablation
  • Abnormal Chemical Recations
  • Adipose Tissue Transplantation
  • Aflatoxin
  • Alcohol Abuse
  • American Syndrome
  • Autopsy
  • Autosomal Recessive
  • Bariatric Surgery
  • Bioinformatics
  • Bioinformatics And Genomic Technology
  • Biomarker
  • Biopsy
  • Bone Marrow Transplant
  • Cancer Immunotherapy
  • Cancer Treatment
  • Cardiovascular Disease
  • Central Obesity
  • Chemoembolization
  • Chemotherapy
  • Cirrhosis
  • Clinical Epigenetics And Biomarkers
  • Clinical Genetics
  • Computerized Tomography
  • Diabetes
  • DNA Methylation
  • DNA Testing
  • Drug Discovery
  • Emerging Focus In Diabetes Research
  • Epidemiology Of Metabolic Syndrome
  • Epigenetics And Metabolism
  • Gene Control By Metabolism
  • Gene Mutation
  • Gene Therapy
  • Genetic Counselling
  • Hemochromatosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma
  • Hepatoma
  • High Blood Pressure
  • Human Genetics
  • Human Health
  • Human Immunodeficiency
  • Human Physiology
  • Immunity Related Disorders
  • Immunosuppression
  • Inborn Error Of Metabolism
  • Insulin Resistance
  • Interferon
  • Internal Radiation Therapy
  • Intrahepatic
  • Laparoscopy
  • Lifestyle Changes
  • Liver Cancer
  • Magnetic Resonance Imaging
  • Medical Research
  • Metabolic Pathway
  • Metastasis
  • Methylation
  • Molecular Biology
  • Molecular Diagnostics
  • Molecular Genetics
  • Nausea
  • Night Sweats
  • Nutrition
  • Nutrition And Cancer
  • Nutrition Transition
  • Obesity
  • Obesity And Oncology
  • Paediatric Diabetes
  • Pediatric Oncologist
  • Phenotypic Heterogeneity
  • Polycystic Ovarian Syndrome
  • Prognosis
  • Psychiatric Illnesses
  • Quality Of Life
  • Radiation
  • Radiation Therapy
  • Radioactive
  • Radiofrequency Ablation
  • Radiologic
  • Regenerative Biology And Stem Cell Research
  • Role Of Anaesthesiologists In Obesity
  • Screening
  • Sedentary Lifestyle
  • Statistical Analysis
  • Statistical Genetics
  • Stem Cell Transplant
  • Stem Cells And Regenerative Medicine
  • Stereotactic
  • Stomach
  • Surgery
  • Systemic
  • Systemic Therapy
  • Targeted Drug Delivery
  • Targeted Therapy
  • Transplantation
  • Tumor Necrosis Factor
  • Tumor Necrosis Factor
  • Type 2 Diabetes
  • Urbanization